This quarter was an exciting step down the path of our second phase. For the third quarter of 2024, our core specialty food service business officially returned to meaningful growth, increasing 5.5% ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

BANGKOK, Nov 13 (Reuters) - Thailand is targeting economic growth of 3.5% in 2025 after 2.7% growth seen this year ... The ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

The first eight spots for the knockout phase of the 2024 Grand Slam of Darts have been distributed. Tuesday night the players ...

Rob Cross has qualified for the knockout phase of the 2024 Grand Slam of Darts. The 34-year-old Englishman defeated Peter ...

“The Phoenix Arts & Innovation District is an opportunity to co-create in partnership with the neighborhood of North ...

Northrop Grumman has completed a preliminary design review for a modernisation of the company’s E-2D Advanced Hawkeye ...

Noodles & Company’s rebound strategy under CEO Drew Madsen faced challenges in the third quarter, with same-store sales ...

The newest character from the Natlan region, a five-star Anemo DPS character named Chasca, is coming in Genshin Impact’s 5.2 ...

MIAMI, Nov. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2024. Highlights from the ...